New onset of autoimmune diseases following COVID-19 diagnosis

AE Gracia-Ramos, E Martin-Nares… - Cells, 2021 - mdpi.com
There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a
dysregulation of the immune system with the development of autoimmune phenomena. The …

Early-stage symptomatic osteoarthritis of the knee—time for action

A Mahmoudian, LS Lohmander, A Mobasheri… - Nature Reviews …, 2021 - nature.com
Osteoarthritis (OA) remains the most challenging arthritic disorder, with a high burden of
disease and no available disease-modifying treatments. Symptomatic early-stage OA of the …

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

C Ponte, PC Grayson, JC Robson, R Suppiah… - Annals of the …, 2022 - ard.bmj.com
Objective To develop and validate updated classification criteria for giant cell arteritis (GCA).
Methods Patients with vasculitis or comparator diseases were recruited into an international …

Sjögren's syndrome: a systemic autoimmune disease

S Negrini, G Emmi, M Greco, M Borro… - Clinical and …, 2022 - Springer
Sjögren's syndrome is a chronic autoimmune disease characterized by ocular and oral
dryness resulting from lacrimal and salivary gland dysfunction. Besides, a variety of systemic …

Primary Sjögren's syndrome

X Mariette, LA Criswell - New England Journal of Medicine, 2018 - Mass Medical Soc
Key Clinical Points Primary Sjögren's Syndrome A diagnosis of primary Sjögren's syndrome
is often made on the basis of a classic triad of symptoms: dryness of the mouth and eyes …

Epithelial–immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis

GM Verstappen, S Pringle, H Bootsma… - Nature Reviews …, 2021 - nature.com
In primary Sjögren syndrome (pSS), the function of the salivary glands is often considerably
reduced. Multiple innate immune pathways are likely dysregulated in the salivary gland …

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

M Ramos-Casals, P Brito-Zerón… - Annals of the …, 2020 - ard.bmj.com
The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in
recent decades: treatment decisions remain challenging in clinical practice, without a …

Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective

J Damoiseaux, LEC Andrade, OG Carballo… - Annals of the …, 2019 - ard.bmj.com
The indirect immunofluorescence assay (IIFA) on HEp-2 cells is widely used for detection of
antinuclear antibodies (ANA). The dichotomous outcome, negative or positive, is integrated …

A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions

ES Dellon, P Khoury, AB Muir, CA Liacouras… - Journal of allergy and …, 2022 - Elsevier
Background & Aims Disease activity and severity of eosinophilic esophagitis (EoE) dictate
therapeutic options and management, but the decision-making process for determining …

Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies

GE Thorlacius, A Björk… - Nature Reviews …, 2023 - nature.com
In primary Sjögren syndrome (pSS), chronic inflammation of exocrine glands results in tissue
destruction and sicca symptoms, primarily of the mouth and eyes. Fatigue, arthralgia and …